(1967) in a colony of beagles maintained as a closed breeding unit. In both these examples, the defect appeared to be an autosomal-recessive affecting both males and females. We report here two further cases discovered in beagles obtained from commercial sources in Great Britain.
MATERIALS AND METHODS

Animals
Both affected dogs are active, healthy females maintained under standard kennel conditions, and were obtained from two separate commercial breeders. They were submitted to laboratory screening tests to ascertain their suitability for use in long-term toxicity studies, and presented haematological and blood-chemistry values within the 110rmal limits for adult beagles, except for certain coagulation tests (see below). The results of routine liver-function tests (plasma transaminase and alkaline phosphatase activities, protein electrophoresis, and bromosulphophthalein clearance) were normal. There were no indications of latent or active helminth infestation. At no time has spontaneous bleeding occurred, and haemorrhage or haematoma formation has never been observed to follow repeated venepuncture (for the routine collection of blood samples). The condition of the animals has remained excellent during the twelve months since receipt into our kennels. An additional 181 female and 51 male beagles have been similarly screened to date without the discovery of further cases.
Collection and preparation of samples
All samples were obtained by clean venepunctures of the cephalic vein of the foreleg or, exceptionally, the saphenous vein of the hind leg, using sterile 20 gauge (0.8 x 40 mm) needles and plastic syringes ('Steriseal', A. R. Horwell Ltd, 2 Grangeway, Kilburn High Road, London, N.W.6) .
For tests requiring derated blood or plasma, the syringe contained sufficient 3.8 per cent (w/v) trisodium citrate solution to give a final ratio of 1 part citrate to 9 parts blood. The blood/citrate mixture was then immediately transferred to polystyrene tubes and gently mixed by rotation on a Matburn Mixer (Allen & Hanburys Ltd, London, E.2). A suitable aliquot was taken for the 'Thrombotest' assay and the plasma was separated from the remainder by centrifugation at 1500 g in the original container. A siliconised pasteur pipette was used to transfer the plasma Into chilled polystyrene tubes kept at 2-4°e. Plasma separation was effected in less than 1 hour from collection, and assays performed within a further 3 hours.
Fresh serum was obtained from whole blood after clotting in clean glass tubes, and separated by centrifugation 1 hour after collection. The serum was aged by storage of the separated serum in glass tubes at 37°e for at least 3 hours.
Alumina-absorbed dog plasma: 1 g of alumina gel (BDH Chemicals Ltd, Poole, Dorset) was shaken with 4 ml distilled water. One part of this suspension was added to 10 parts of normal citrated plasma and incubated for 3 minutes at 37°C. The alumina was removed by centrifuging, the supernatant providing a plasma rich in factors V and VIII, but with very little of factors II, VII, IX and X.
Factor V-deficient dog plasma was prepared by maintaining oxalated plasma (1 part of 1.34 per cent (w/v) sodium oxalate to 9 parts of blood) at 37°C for at least 5 hours, with subsequent storage at 4°C until the one-stage prothrombin time was prolonged to at least 60 seconds when using dog-brain thromboplastin.
Factor Vll-deficient citra ted blood and plasma were obtained by collection 18 hours after the administration of the second of two consecutive daily doses of 'Dindevan' (Duncan, Flockhart & Evans Ltd, Birkbeck Street, London, E.2), 10 mg/kg orally, to a normal beagle.
Whole blood for platelet counts was immediately transferred to a 1 ml polystyrene tube containing dipotassium sequestrene (prepared tubes obtained from Teklab Medical Laboratories Ltd, Hockley, Essex), and mixed.
Laboratory procedures
These assays were carried out in accordance with the general principles advocated by Biggs & Macfarlane (1962) and Denson (1966) . In certain cases the assays were modifi~d by the use of different reagents, as indicated in the text.
Whole-blood clotting time (method of Lee & White).
Quick's one-stage prothrombin time using either rabbit brain thromboplastin (Activated Reagent, Dade Reagents Inc., Miami, Florida, U.S.A., obtained from A. R. Horwell Ltd, London, N.W.6) or dog-brain thromboplastin prepared in this laboratory from a recently killed beagle. Factor VII activity assay, using as substrate absorbed bovine plasma as prepared for the P and P method (Diagnostic Reagents Ltd, Thame, Oxon.).
Platelet count, using as diluent 1 per cent formalin in 3 per cent (wJv) trisodium citrate (Dacie & Lewis. 1963) .
RESULTS
Both affected beagles exhibited normal whole-blood clotting time, platelet count, two-stage prothrombin and prothrombin consumption time, plasma recalcification time, kaolin-cephalin time and fibrinogen titre. The thromboplastin generation test was also normal. The Quick's one-stage prothrombin time using either rabbit-or dog-brain thromboplastin was lengthened, although the Russell's viper venom time was normal.
The 'Thrombotest' time was also prolonged.
Factor VII activity was reduced when compared with that of a normal beagle (Table 1) .
Prothrombin % (two-stage) Fibrinogen titre (ratio) Platelets x 10"/mm" (range)
Factor VII assay % (rabbit brain) (dog brain) Addition of appropriate reagents to a one-stage system incorporating recalcified defective plasma and dog-brain thromboplastin, showed that normal plasma, factor V-deficient plasma and, more especially, serum (all of canine origin) shortened the one-stage times of plasma from both beagles to normal. By contrast, alumina-absorbed canine plasma, deficient in factor VII, had no effect. Similar results were obtained in one-stage systems using rabbit-brain thromboplastin and 'Thrombotest' (Tables 2 and 3) . Normal canine plasma, and especially serum, shortened the prothrombin and 'Thrombotest' times given by blood or plasma from 'Dindevan'-treated beagles, whereas plasma from either affected animal had no effect. A slight shortening was, however, observed with the addition of serum from them (Table 4 ).
Normal plasma
Alumina-absorbed plasma Factor V-deficient plasma 
7.4
Single doses of vitamin Kl ('Konakion', Roche Products Ltd, Welwyn Garden City, Herts.) given to one of the beagles (174) had no effect on the prothrombin and 'Thrombotest' times of this animal, when determined 21 hours after the administration of 20 mg of the vitamin subcutaneously, or 5 hours after the administration of 10 mg intravenously.
DISCUSSION
In man, the diagnosis of uncomplicated factor VII deficiency is based on a demonstration of a one-stage prothrombin time which is prolonged with brain thromboplastin, but normal with Russell's viper venom and lipid. The whole-blood clotting time, prothrombin consumption index and thromboplastin generation test are normal (Biggs & Macfarlane, ]966). The prolonged one-stage time using brain is corrected by normal serum but not by alumina-absorbed plasma (Biggs & Macfarlane, ]962). In the presence of a normal Russell's viper venom time, factor X deficiency is excluded. The administration of a coumarin-like anticoagulant such as 'Dindevan' initially produces depression of factor VII, followed by a fall in factor X and factor II activity subsequent to further treatment.
The demonstration, therefore, of reduced factor VII activity following anticoagulant treatment depends on FACTOR VII DEFlCIENCY IN BEAGLES 111 proof that other clotting factors are not affected. The results obtained with plasma from our beagles indicate, using the above criteria, that an uncomplicated factor VB-like deficiency exists in these two animals.
There are some differences between our results and those obtained for the two previous reports of this deficiency in the dog. The prolonged prothrombin times observed by other workers appear to be associated with little or no factor VII activity (Garner et aI., 1967; Hovig, Rowsell, Dodds, J0rgensen & Mustard, 1967) . The less prolonged prothrombin times observed in our two animals, together with a factor VII activity of approximately 25 per cent of that of a normal dog (Table 1) , suggests the existence of a less severe deficiency. These differences may be a direct consequence of the use of different brain thromboplastins and test systems, or they may indicate the presence of a heterozygous condition which would be demonstrated by controlled breeding. We do not consider the absence of physical bleeding in our beagles to be a reliable indicator in this respect since none of the known cases of factor VII deficiency associated with activity levels of 7 per cent or less have shown clinically a tendency to bleed (Mustard et at., 1962; Dodds, Packham, Roswell & Mustard, 1967; Garner, 1968, personal communication) . It has recently been shown that haemostatic plugs formed in cut vessels of dogs deficient in factor VII do not differ substantially from those seen in normal dogs (Hovig et at., 1967) . These findings are in marked contrast to the often severe bleeding syndromes seen in deficiencies of factors VIII (haemophilia) and IX (Christmas disease), in which haemostatic plugs are defective (Graham, Buckwalter, Hartley & Brinkhous, 1949; Mustard, Rowsell, Robinson, Hoeksema & Downie, 1960; Hovig et at., 1967) .
The diagnosis of this disorder in beagles would seem, therefore, to rely solely on results of appropriate coagulation tests carried out in vitro. Since the one-stage prothrombin time and 'Thrombotest' both give prolonged times in this disorder, confusion could arise where such tests were used as a measure of liver function in, for example, toxicological studies, in the absence of a preliminary screening of dogs for the existence of the disorder. It is our opinion that, since the performance of these tests is relatively simple, screening of beagles for the presence of this defect should present no problem and could usefully be added to the battery of conventional haematological tests customarily used to provide baseline data. Both rabbit-brain thromboplastin and 'Thrombotest' are available commercially, and since our results show that the defect can be detected with these reagents in the manner described above, dog brain is not essential as the source of thromboplastin, although it is advocated that a homologous system is preferable (Archer, 1965) , and species specificity in this reaction has been demonstrated (Stormoken, 1957; Didisheim, Hattori & Lewis, 1959) . The existence of this disorder in otherwise normal beagles indicates a need for alertness on the part of breeders and potential users for the possible consequences of closed-colony inbreeding, including the spread of inheritable blood-coagulation defects not readily apparent by physical examination.
